Literature DB >> 9300680

IL-4-independent regulation of in vivo IL-9 expression.

P Monteyne1, J C Renauld, J Van Broeck, D W Dunne, F Brombacher, J P Coutelier.   

Abstract

We focused on the role of IL-4 in the regulation of the Th2 cytokine IL-9. In vivo, IL-9 mRNA was detected in lymph nodes after immunization with soluble Ags. IL-9 expression preceded that of IL-4, and was not affected in IL-4 knockout mice. In contrast, a significant decrease of IL-9 message was observed in IL-10-deficient mice, indicating a role for this cytokine in the induction of IL-9 production. Treatment with anti-CD4 Ab and analysis of purified CD4 cells confirmed that IL-9 was produced by CD4+ cells. Moreover, similarly to what has been reported for IL-4, IL-9 message induction was strongly decreased by infection with lactate dehydrogenase-elevating virus. IL-9 mRNA was also detected after in vivo stimulation with anti-CD3 Ab. In this model, IL-9 expression followed that of IL-4, but was not reduced in IL-4-deficient mice. This contrasts with in vitro stimulation in which, as reported in humans, IL-9 expression in lymphocytes incubated with anti-CD3 Ab and costimulatory molecules appeared as a late event, and was partly dependent on IL-4. In vitro IL-9 secretion was reduced significantly by addition of anti-IL-4 Ab, as well as in lymphocytes from IL-4 gene-deficient mice. Taken together, our results indicate that the Th2 cytokine IL-9 can be expressed by both IL-4-dependent and -independent pathways.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9300680

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  19 in total

Review 1.  Cytokines in asthma.

Authors:  K F Chung; P J Barnes
Journal:  Thorax       Date:  1999-09       Impact factor: 9.139

2.  Nuclear factor of activated T cells 1 (NFAT1)-induced permissive chromatin modification facilitates nuclear factor-κB (NF-κB)-mediated interleukin-9 (IL-9) transactivation.

Authors:  Arijita Jash; Anupama Sahoo; Gi-Cheon Kim; Chang-Suk Chae; Ji-Sun Hwang; Jung-Eun Kim; Sin-Hyeog Im
Journal:  J Biol Chem       Date:  2012-03-15       Impact factor: 5.157

3.  IL-9 is important for T-cell activation and differentiation in autoimmune inflammation of the central nervous system.

Authors:  Hongmei Li; Bardia Nourbakhsh; Melissa Cullimore; Guang-Xian Zhang; Abdolmohamad Rostami
Journal:  Eur J Immunol       Date:  2011-07-06       Impact factor: 5.532

4.  Acute and chronic phases of Toxoplasma gondii infection in mice modulate the host immune responses.

Authors:  T D Nguyen; G Bigaignon; J Van Broeck; M Vercammen; T N Nguyen; M Delmee; M Turneer; S F Wolf; J P Coutelier
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

Review 5.  New insights into the role of cytokines in asthma.

Authors:  J C Renauld
Journal:  J Clin Pathol       Date:  2001-08       Impact factor: 3.411

Review 6.  IL-9: basic biology, signaling pathways in CD4+ T cells and implications for autoimmunity.

Authors:  Hongmei Li; Abdolmohamad Rostami
Journal:  J Neuroimmune Pharmacol       Date:  2009-12-18       Impact factor: 4.147

Review 7.  Th9 and allergic disease.

Authors:  Pejman Soroosh; Taylor A Doherty
Journal:  Immunology       Date:  2009-08       Impact factor: 7.397

8.  Regulation of IL-9 expression by IL-25 signaling.

Authors:  Pornpimon Angkasekwinai; Seon Hee Chang; Manoj Thapa; Hiroshi Watarai; Chen Dong
Journal:  Nat Immunol       Date:  2010-02-14       Impact factor: 25.606

9.  Disruption of Th2 immunity results in a gender-specific expansion of IL-13 producing accessory NK cells during helminth infection.

Authors:  Matthew R Hepworth; Richard K Grencis
Journal:  J Immunol       Date:  2009-08-19       Impact factor: 5.422

10.  Antigen-induced increases in pulmonary mast cell progenitor numbers depend on IL-9 and CD1d-restricted NKT cells.

Authors:  Tatiana G Jones; Jenny Hallgren; Alison Humbles; Timothy Burwell; Fred D Finkelman; Pilar Alcaide; K Frank Austen; Michael F Gurish
Journal:  J Immunol       Date:  2009-09-25       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.